B-Raf — Drug Target
All drugs that target B-Raf — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (1)
- Anti-B-RAF · Istituto Oncologico Veneto IRCCS · B-Raf inhibitor · Oncology
Anti-B-RAF drugs target and inhibit the B-Raf protein, which is often mutated in cancer cells.